RELN and Alzheimer disease: However, neuropathological examination confirmed the RELN-COLBOS carrier had severe AD pathology (Braak stage VI), so although the RELN-COLBOS variant substantially delayed onset, it did not prevent typical neuropathological progression by end stage.